ACAD

Acadia Pharmaceuticals Stock Analysis

AI Rating

Great
  • Quality8/10
  • Growth↑ 8/10
  • Momentum↑ 5/10
Acadia Pharmaceuticals sales and earnings growth
ACAD Growth
Good
  • Revenue Y/Y↑ 12.69%
  • EPS Y/Y↑ 101.28%
  • FCF Y/Y↓ -2.39%
Acadia Pharmaceuticals gross and profit margin trends
ACAD Profitability
Good
  • Gross margin ↑ 91.90%
  • EPS margin↑ 24.90%
  • ROIC↑ 51.70%
Acadia Pharmaceuticals net debt vs free cash flow
ACAD Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Acadia Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗